Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.


Summaries of Product Characteristics 61 - 90 of 321
Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

European Medicines Agency's website:
Darunavir Krka d.d. - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Darunavir Medical Valley 600 mg tabletti, kalvopäällysteinen SPC 2024-02-29 Uusi

PL

Resepti

Darunavir Medical Valley 800 mg tabletti, kalvopäällysteinen SPC 2024-02-29 Uusi

European Medicines Agency's website:
Darunavir Mylan - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Darunavir Sandoz 600 mg tabletti, kalvopäällysteinen SPC 2023-07-12

PL

Resepti

Darunavir Sandoz 800 mg tabletti, kalvopäällysteinen SPC 2023-07-12

PL

Resepti

Darunavir STADA 600 mg tabletti, kalvopäällysteinen SPC 2023-10-24

PL

Resepti

Darunavir STADA 800 mg tabletti, kalvopäällysteinen SPC 2023-10-24

European Medicines Agency's website:
Darzalex - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Dasatinib Accord - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Dasatinib Accordpharma - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Dasatinib Avansor 50 mg tabletti, kalvopäällysteinen SPC 2024-02-02

PL

Resepti

Dasatinib Krka 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, 140 mg tabletti, kalvopäällysteinen SPC 2023-04-12

PL

Resepti

Dasatinib Sandoz 20 mg, 50 mg, 70 mg, tabletti, kalvopäällysteinen SPC 2023-03-16

PL

Resepti

Dasatinib Stada tabletti, kalvopäällysteinen 20 mg, 50 mg, 70 mg, 80 mg, 100mg,140 mg SPC 2024-04-24

PL

Resepti

Dasatinib Viatris 20 mg, 50 mg, 70 mg, 100 mg tabletti, kalvopäällysteinen SPC 2023-10-26

PL

Resepti

Dasergin 5 mg tabletti, kalvopäällysteinen SPC 2024-04-23.doc Uusi

European Medicines Agency's website:
Dasselta - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
DaTSCAN - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Daurismo - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Daxas - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Daylette 0,02 mg-3 mg tabletti, kalvopäällysteinen SPC 203-01-30

PL

Resepti

Deca-Durabolin 50 mg-ml injektioneste, liuos SPC 2023-05-31

European Medicines Agency's website:
Dectova - EMA: EPAR PI
Finnish Swedish

European Medicines Agency's website:
Deferasirox Accord - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Deferasirox Glenmark 90 mg, 180 mg, 360 mg tabletti, kalvopäällysteinen SPC 2023-04-26

European Medicines Agency's website:
Deferasirox Mylan - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Deferasirox Orifarm 90 mg, 180 mg, 360 mg kalvopäällysteiset tabletit, SPC 2023-01-18

PL

Resepti

Deferasirox Stada 90 mg, 180 mg, 360 mg kalvopäällysteinen tabletti, SPC 2020-09-02

European Medicines Agency's website:
Deferiprone Lipomed - EMA: EPAR PI
Finnish Swedish

Previous 30    |  1  2  3  4  5  6  7  8  9  10  11  |  Next 30   >